Type III Dysbetalipoproteinemia

This study has been completed.

Study NCT00214604 Information provided by AstraZeneca

First Received: September 21, 2005 Last Updated: November 18, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2007
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)